Who May Benefit Most From Long Term Use People with obesity, type 2 diabetes, insulin resistance, metabolic syndrome, or cardiovascular disease often benefit most from long term GLP-1 therapy
GLP-1 medications are designed to be injected into fatty tissue just beneath the skin
One nuance worth knowing : if your BMI is under 25 or you have minimal abdominal fat, you may find the thigh easier to work with than the abdomen
If you are prone to sleep disturbances on GLP-1 therapy , evening injection might worsen the problem rather than solve it
Patients with chronic conditions who require lifelong medication need enhanced comfort to manage their treatment, particularly when self-administering complex, large-volume, high-value biologic drugs, such as monoclonal antibodies, says Severine Duband, Category Director, Devices, Nemera
Postgrad Med